EVERSANA announces broad-scale strategic partnerships with industry leaders in claims, EMR, formulary and provider-institutional data to optimize real-time commercial services EVERSANA and Symphony Health announce multi-year relationship for EMR claims and data infrastructure EVERSANA and Compile partner to integrate physician affiliation data to drive market access commercial services, with additional formulary data partnership in final […]

W2O announced two new products available through Symplur, the company’s social media analytics platform dedicated exclusively to the healthcare industry.

EVERSANA launched ACTICS by EVERSANA, a technology-enabled solution to optimize end-to-end commercial success for life science companies.

At least four of six different vaccine candidates financially backed by the U.S. government aimed at the novel coronavirus are predicted to fail in the clinic, according to a draft report from an analytics group cited by CNBC.

EVERSANA announced a partnership with the Institute for Clinical and Economic Review (ICER) to advance standards for the usage of transparent, replicable and robust indirect treatment comparisons in health technology assessments.

EVERSANA, a leading provider of commercial services to the life science industry, announced the acquisition of HVH Precision Analytics and its predictive analytics platform.

W2O – a leading independent provider of analytics-driven, digital-first marketing communications to the healthcare sector – announced that Bryan Specht was named Group President, Transformation, Consumer Activation and Marketing.

Med Ad News talked to HVH Precision Analytics, a joint venture with Havas Health & You and Vencore specializing in AI and machine learning data analytics, about the company’s efforts at the forefront of rare disease work.

W2O acquired Symplur, a social media analytics platform exclusively focused on the healthcare sector.

A quarter of healthcare organizations’ revenue is tied to value-based payments, according to a survey by the healthcare data analytics and policy company DataGen. Those with 550 or more beds reported the largest portion of risk, with an average of 37.9 percent of revenue tied to VBP.